Breztri Aerosphere budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation Images

Generic Name: budesonide/formoterol/glycopyrrolate

This medication has been identified as Breztri Aerosphere budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation. It is supplied by AstraZeneca.

Breztri Aerosphere is used in the treatment of COPD, Maintenance; COPD and belongs to the drug class bronchodilator combinations. Breztri Aerosphere budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Breztri Aerosphere

Generic Name

budesonide/formoterol/glycopyrrolate

Strength

budesonide 160 mcg, glycopyrrolate 9.0 mcg, and formoterol fumarate 4.8 mcg per inhalation

Availability

Prescription only

Drug Class

Bronchodilator combinations

CSA Schedule

Not a controlled drug

Labeler / Supplier

AstraZeneca

National Drug Code (NDC)

00310-4616

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer